nitroaspirin has been researched along with Embolism, Pulmonary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gresele, P; Mezzasoma, AM; Momi, S | 1 |
Alberti, PF; Del Soldato, P; Gresele, P; Minuz, P; Momi, S; Pitchford, SC | 1 |
Del Soldato, P; Emerson, M; Gresele, P; Leone, M; Mezzasoma, AM; Momi, S; Page, CP; Paul, W | 1 |
3 other study(ies) available for nitroaspirin and Embolism, Pulmonary
Article | Year |
---|---|
NCX4016: a novel antithrombotic agent.
Topics: Animals; Aspirin; Blood Platelets; Disease Models, Animal; Fibrinolytic Agents; Humans; In Vitro Techniques; Mice; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rabbits; Rats | 2003 |
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Topics: Animals; Aspirin; Blood Coagulation Tests; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Hemorrhage; Male; Mice; Mice, Inbred Strains; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Survival Rate; Thromboembolism; Ticlopidine; Tunica Intima | 2005 |
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Lung; Male; Mice; Nitroarginine; Platelet Aggregation Inhibitors; Platelet Count; Pulmonary Artery; Pulmonary Embolism; Rabbits; Thrombin; Thrombosis | 2000 |